> Off-target toxicity is a common mechanism of action of cancer drugs undergoing clinical trials
> . Lin et al. discovered that a drug candidate in clinical development was effective at killing cancer cells even when its target protein was knocked out, suggesting that its proposed mechanism of action was incorrect. The researchers then identified multiple drugs with similar problems